Biomarkers are used for diagnostic, prognostic, and predictive purposes.
They play key roles in the diagnosis, progression, and management of diseases. The
roles of biomarkers are as follows: diagnostic biomarkers help recognize precise
diseases, such as troponin levels representing heart attacks, prognostic biomarkers offer
insights into disease development or outcomes, like gene profiles predicting cancer
survival, and predictive biomarkers forecast treatment responses, such as HER2 status
guiding breast cancer therapy. Biomarkers are transforming modern medicine by
facilitating personalized and targeted treatment approaches, enabling more precise,
effective, and individualized therapeutic strategies. Biomarkers are measurable
biological indicators, such as molecules, genes, or other markers of disease, that play a
pivotal role in advancing healthcare by providing a deeper understanding of disease
biology at the individual level. They are critical not only for diagnosing and predicting
the progression of various conditions but also for guiding the selection of optimal
treatments tailored to specific patient populations. The emergence of personalized
medicine, which leverages individual biomarkers to create customized treatment plans,
represents a groundbreaking shift in contemporary healthcare. This chapter delves into
the significant roles of biomarkers in driving advancements in personalized and
targeted therapies, with a particular focus on their utilization in oncology,
cardiovascular diseases, and neurological disorders. Additionally, it highlights
emerging trends and technologies in biomarker discovery, addresses challenges in
clinical implementation, and explores future directions for this rapidly evolving field.
Keywords: Advancing healthcare, Biomarkers, Clinical research, Personalized medicine, Precision oncology, Targeted treatment, Therapeutic intervention.
